Advertisement

Topics

Natera sélectionnée pour une étude sur l'ADN tumoral circulant dans le cadre du cancer colorectal

06:19 EST 7 Nov 2017 | BioMedReports - Blog

Cette deuxième étude évaluera 130 patients atteints d'un cancer colorectal en phase I-III précédemment traité par chirurgie et chimiothérapie adjuvante, puis les surveillera de manière

Related Biotechnology, Pharmaceutical and Healthcare News

Read more...

Original Article: Natera sélectionnée pour une étude sur l'ADN tumoral circulant dans le cadre du cancer colorectal

NEXT ARTICLE

More From BioPortfolio on "Natera sélectionnée pour une étude sur l'ADN tumoral circulant dans le cadre du cancer colorectal"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.